工程化多特异性抗体:在免疫治疗领域的新前沿
Sandeep1, Suraj H Shinde1, Sakeel Ahmed2
1Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, India.
Immunology
|December 23, 2023
概括
多特异性单克隆抗体 (PsAbs) 与单特异性抗体相比,提供了更好的疗效. 本综述涵盖了它们的发展,质量控制,以及在癌症免疫疗法和其他疾病中的重大前景.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 制药科学 制药科学
背景情况:
- 单特异单克隆抗体 (MAbs) 已经取得了成功,但多特异MAbs (PsAbs) 正成为一个有希望的进步.
- 能够用单个抗体结合多个点的PsAbs被假设可以增强免疫防御能力.
- 制药行业正在经历 PsAbs. 的兴趣和发展的激增.
研究的目的:
- 审查多特异性MAbs (PsAbs) 的当前发展和质量执行情况.
- 强调PsAbs.日益增长的重要性和治疗潜力.
主要方法:
- 在主要的科学数据库 (PubMed,谷歌学者,科学网等) 进行全面的文献搜索. 和专利数据库.
- 使用的关键词包括"抗体工程"",多特异性抗体"",常规抗体"",非常规抗体"和"单域抗体".
- 对PsAbs的各种构造格式的分析,包括四边形技术,化学合和基因工程.
主要成果:
- 为了构建PsAbs.存在超过100种不同的格式.
- 截至2023年3月,全球已有9个PsAbs获得批准,大约有330个处于高级开发阶段.
- 最近的蛋白质工程进步使复杂的PsAbs具有增强的稳定性和功效.
结论:
- 在不断发展的健康领域,psAbs表现出显著的主导地位.
- PsAbs对癌症免疫疗法有着巨大的前景,在九种批准的PsAbs中,有七种用于抗癌疗法.
- PsAbs的持续突出地位可能会导致一系列疾病的新型免疫疗法.
相关概念视频
01:31Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
01:10Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K